152 results on '"Jansen, Marnix"'
Search Results
2. Multi-scale Deformable Transformer for the Classification of Gastric Glands: The IMGL Dataset
3. Epigenome and early selection determine the tumour-immune evolutionary trajectory of colorectal cancer
4. Poor diagnostic reproducibility in the identification of non-conventional dysplasia in colitis impacts the application of histological stratification tools
5. Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
6. 300. ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED SUBMUCOSAL ESOPHAGEAL ADENOCARCINOMA: PRELIMINARY RESULTS OF AN ONGOING PROSPECTIVE, INTERNATIONAL, MULTICENTER COHORT REGISTRY (PREFER TRIAL)
7. 223 IMMUNE CELL PHENOTYPING IN BARRETT'S ESOPHAGUS IN PATIENTS PRIOR AND AT TIME OF PROGRESSION
8. Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of oesophagael adenocarcinoma
9. Abstract 4539: Tumor evolution and immune microenvironment dynamics define response to neoadjuvant treatment of esophageal adenocarcinoma
10. Figure S2 from Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry
11. Figure S5 from Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry
12. Supplemental methods and tables from Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry
13. Figure S6 from Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry
14. Supplementary Information from Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry
15. Supplemental methods and tables from Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry
16. Supplementary Information from Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry
17. Figure S1 from Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry
18. A Probabilistic Model Combining Deep Learning and Multi-atlas Segmentation for Semi-automated Labelling of Histology
19. A digital pathology workflow for the segmentation and classification of gastric glands: Study of gastric atrophy and intestinal metaplasia cases
20. The co-evolution of the genome and epigenome in colorectal cancer
21. Phenotypic plasticity and genetic control in colorectal cancer evolution
22. Phase 0 Study of Vandetanib-Eluting Radiopaque Embolics as a Preoperative Embolization Treatment in Patients with Resectable Liver Malignancies
23. Gland segmentation in gastric histology images: detection of intestinal metaplasia
24. Analysis of metastases rates during follow-up after endoscopic resection of early “high-risk” esophageal adenocarcinoma
25. The Need for Routine Native Nephrectomy in the Workup for Kidney Transplantation in Autosomal Dominant Polycystic Kidney Disease Patients
26. ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED SUBMUCOSAL ADENOCARCINOMA IN BARRETT’S ESOPHAGUS: EARLY RESULTS OF AN ONGOING PROSPECTIVE, INTERNATIONAL, MULTICENTER COHORT REGISTRY (PREFER TRIAL)
27. P110 Cytosponge for risk stratification in patients with Barrett’s oesophagus overdue endoscopic surveillance due to COVID-19
28. NEOPRISM-CRC: Neoadjuvant pembrolizumab stratified to tumor mutation burden for high-risk stage 2 or stage 3 deficient-MMR/MSI-high colorectal cancer.
29. Mo1164: UTILISATION OF THE CYTOSPONGE DEVICE AS A TOOL FOR RISK STRATIFICATION IN PATIENTS WITH BARRETT'S OESOPHAGUS WHO ARE OVERDUE ENDOSCOPIC SURVEILLANCE DUE TO THE COVID-19 PANDEMIC
30. Immunosuppressive niche engineering at the onset of human colorectal cancer
31. Clonal Transitions and Phenotypic Evolution in Barrett’s Esophagus
32. What Makes an Expert Barrett’s Histopathologist?
33. Distal Esophageal Adenocarcinoma and Gastric Adenocarcinoma: Time for a Shared Research Agenda
34. The Japanese Viewpoint on the Histopathology of Early Gastric Cancer
35. Histopathology-led quality evaluation of endoluminal excision specimens – not a bad idea!
36. Three-dimensional tumour microenvironment reconstruction and tumour-immune interactions' analysis
37. HFR-1 Cytosponge as a risk stratification tool in patients overdue barrett’s surveillance due to Covid-19
38. Endoscopic tissue sampling – Part 2: Lower gastrointestinal tract. European Society of Gastrointestinal Endoscopy (ESGE) Guideline
39. Extension of early esophageal squamous cell neoplasia into ducts and submucosal glands and the role of endoscopic ablation therapy
40. Tertiary lymphoid structures (TLS) identification and density assessment on H&E-stained digital slides of lung cancer
41. Endoscopic tissue sampling – Part 1: Upper gastrointestinal and hepatopancreatobiliary tracts. European Society of Gastrointestinal Endoscopy (ESGE) Guideline
42. The co-evolution of the genome and epigenome in colorectal cancer
43. Immunosuppressive niche engineering at the onset of human colorectal cancer
44. The natural history of low‐grade dysplasia in Barrett's esophagus and risk factors for progression
45. Dataset for the reporting of carcinoma of the esophagus in resection specimens: recommendations from the International Collaboration on Cancer Reporting
46. Phenotypic plasticity and genetic control in colorectal cancer evolution
47. Assessment of the evolutionary consequence of putative driver mutations in colorectal cancer with spatial multiomic data
48. The co-evolution of the genome and epigenome in colorectal cancer
49. Wisdom Of The Crowd For Early Detection In Barrett’s Esophagus
50. Clonal transitions and phenotypic evolution in Barrett esophagus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.